跳至主要内容
临床试验/NL-OMON44534
NL-OMON44534已完成4 期

The effect of sitagliptin on brown adipose tissue and whole-body metabolism in overweight pre-diabetic men - Sitagliptin and brown adipose tissue

Merck Sharp & Dohme (MSD)0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Male volunteers, 30 Caucasians, born in the Netherlands
  • - Age: 35-55 years
  • - BMI * 25 and * 35 kg/m2
  • - Plasma glucose levels 2 h after OGTT between 7.8 and 11 mM (e.g. impaired glucose tolerance) or fasted plasma glucose >5.6 mM

排除标准

  • - Diabetes mellitus (determined on basis of oral glucose tolerance test (OGTT) defined by ADA criteria
  • - BMI > 35 kg/m2 or < 25 kg/m2
  • - Plasma glucose levels 2 h after OGTT < 7.8 mM or > 11.1 mM
  • - Use of medication known to influence glucose and/or lipid metabolism or BAT activity (e.g. beta blockers)
  • - Any significant chronic disease
  • - Renal, hepatic or endocrine disease
  • - Participation in an intensive weight-loss program or vigorous exercise program during the last year before the start of the study
  • - Difficulties to insert an intravenous catheter
  • - Recent participation in other research projects (within the last 3 months), participation in 2 or more projects in one year

研究者

发起方
Merck Sharp & Dohme (MSD)

相似试验

The effect of sitagliptin on brown adipose tissue... | 临床试验